Gene: ARSL
Official Full Name: arylsulfatase Lprovided by HGNC
Gene Summary: Arylsulfatase E is a member of the sulfatase family. It is glycosylated postranslationally and localized to the golgi apparatus. Sulfatases are essential for the correct composition of bone and cartilage matrix. X-linked chondrodysplasia punctata, a disease characterized by abnormalities in cartilage and bone development, has been linked to mutations in this gene. Alternative splicing results in multiple transcript variants. A pseudogene related to this gene is located on the Y chromosome. [provided by RefSeq, Sep 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38911 | ARSL Knockout cell line (HEK293) | Human | ARSL | 1:3~1:6 | Negative | Online Inquiry |
KO38912 | ARSL Knockout cell line (A549) | Human | ARSL | 1:3~1:4 | Negative | Online Inquiry |
ARSL Gene Knockout Cell Lines are genetically modified cell lines specifically created to disable or "knock out" the activity of the argininosuccinate lyase (ARSL) gene. This gene is instrumental in the urea cycle, a critical metabolic pathway responsible for the conversion of ammonia into urea in the liver. The knockout of ARSL provides researchers with a valuable tool to investigate the gene's role in various metabolic disorders, particularly those associated with hyperammonemia and argininemia.
The key functions of these cell lines include modeling the pathophysiological effects of ARSL deficiency and providing a platform for studying compensatory pathways and alternative metabolism in the absence of functional ARSL. By employing CRISPR-Cas9 technology for precise gene editing, these cell lines exhibit high specificity and efficiency in gene knockout, ensuring that researchers obtain meaningful and reproducible results.
Scientifically, ARSL Gene Knockout Cell Lines have wide-ranging applications. Their use extends to basic research in metabolic biology, drug discovery, and the development of gene therapies aimed at correcting metabolic dysfunctions. Clinically, these cell lines can contribute to the understanding of ARSL-related pathologies, facilitating the discovery of biomarkers and therapeutic targets.
Compared to alternative models, our ARSL Gene Knockout Cell Lines stand out due to their robust phenotype representation and validated performance in multiple experimental settings. Researchers benefit from the time-saving convenience of ready-to-use lines that have undergone rigorous characterization and quality control.
The value of these cell lines to researchers and clinicians lies in their ability to mimic natural disease conditions, thereby accelerating the pace of scientific inquiry and therapeutic development. By utilizing these cell lines, users can enhance their research outcomes, contribute to advanced understanding of metabolic diseases, and expedite translational research efforts.
Our company specializes in providing high-quality genetic models and tools for biomedical research, backed by a commitment to innovation and scientific excellence. Through our expertise, we ensure that our ARSL Gene Knockout Cell Lines meet the rigorous demands of the research community, offering unparalleled support and reliability for groundbreaking studies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.